Image of Quadrivalent HPV Vaccination and the Risk of Adverse Pregnancy Outcomes

LITERATURE

Quadrivalent HPV Vaccination and the Risk of Adverse Pregnancy Outcomes


The quadrivalent human papillomavirus (HPV) vaccine is recommended for all girls and women 9 to 26 years of age. Some women will have inadvertent exposure to vaccination during early pregnancy, but few data exist regarding the safety of
the quadrivalent HPV vaccine in this context


Availability

REQJ494-02Titan CenterAvailable

Detail Information

Series Title
-
Call Number
-
Publisher : .,
Collation
-
Language
English
ISBN/ISSN
-
Classification
NONE
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
Specific Detail Info
N Engl J Med 2017;376:1223-33
Statement of Responsibility

Other version/related

No other version available


File Attachment



Information


RECORD DETAIL


Back To Previous